Affinity Investment Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-5,838
| Closed | -$1.03M | – | 160 |
|
|
2020
Q1 | $1.03M | Sell |
5,838
-11,600
| -67% | -$2.18M | 0.53% | 50 |
|
|
2019
Q4 | $3.33M | Sell |
17,438
-9,278
| -35% | -$1.67M | 1.21% | 38 |
|
|
2019
Q3 | $4.5M | Sell |
26,716
-7,273
| -21% | -$1.18M | 1.41% | 32 |
|
|
2019
Q2 | $5.69M | Sell |
33,989
-22,357
| -40% | -$3.1M | 1.63% | 18 |
|
|
2019
Q1 | $8.25M | Sell |
56,346
-13,720
| -20% | -$1.99M | 1.69% | 22 |
|
|
2018
Q4 | $9.37M | Sell |
70,066
-4,388
| -6% | -$719K | 1.64% | 23 |
|
|
2018
Q3 | $14.2M | Buy |
74,454
+11,012
| +17% | +$2.02M | 1.87% | 14 |
|
|
2018
Q2 | $10.6M | Buy |
63,442
+157
| +0.2% | +$25.2K | 1.49% | 22 |
|
|
2018
Q1 | $10.7M | Buy |
63,285
+1,101
| +2% | +$185K | 1.24% | 38 |
|
|
2017
Q4 | $10.2M | Buy |
62,184
+2,875
| +5% | +$516K | 1.15% | 40 |
|
|
2017
Q3 | $12.2M | Buy |
59,309
+12,330
| +26% | +$2.87M | 1.41% | 31 |
|
|
2017
Q2 | $11.4M | Sell |
46,979
-7,819
| -14% | -$1.84M | 1.36% | 30 |
|
|
2017
Q1 | $13.1M | Buy |
54,798
+4,347
| +9% | +$1.01M | 1.18% | 35 |
|
|
2016
Q4 | $10.6M | Sell |
50,451
-6,311
| -11% | -$1.31M | 1% | 46 |
|
|
2016
Q3 | $13.1M | Sell |
56,762
-10,096
| -15% | -$2.47M | 1.11% | 40 |
|
|
2016
Q2 | $15.4M | Buy |
66,858
+2,991
| +5% | +$690K | 1.14% | 38 |
|
|
2016
Q1 | $17.1M | Sell |
63,867
-693
| -1% | -$198K | 1.5% | 22 |
|
|
2015
Q4 | $20.2M | Buy |
64,560
+299
| +0.5% | +$89K | 1.73% | 13 |
|
|
2015
Q3 | $17.5M | Sell |
64,261
-604
| -0.9% | -$186K | 1.59% | 20 |
|
|
2015
Q2 | $19.7M | Sell |
64,865
-2,659
| -4% | -$793K | 1.57% | 17 |
|
|
2015
Q1 | $20.1M | Buy |
67,524
+7,982
| +13% | +$2.28M | 1.45% | 23 |
|
|
2014
Q4 | $15.3M | Sell |
59,542
-3,970
| -6% | -$992K | 1.42% | 31 |
|
|
2014
Q3 | $15.3M | Sell |
63,512
-10,178
| -14% | -$2.28M | 1.55% | 21 |
|
|
2014
Q2 | $16.4M | Sell |
73,690
-12,564
| -15% | -$2.6M | 1.86% | 16 |
|
|
2014
Q1 | $17.8M | Sell |
86,254
-10,769
| -11% | -$2.13M | 2.09% | 9 |
|
|
2013
Q4 | $16.3M | Sell |
97,023
-6,963
| -7% | -$1.09M | 1.98% | 12 |
|
|
2013
Q3 | $15M | Sell |
103,986
-67,344
| -39% | -$8.97M | 1.94% | 13 |
|
|
2013
Q2 | $21.6M | Buy |
+171,330
| New | +$19.4M | 1.88% | 15 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Affinity Investment Advisors's AGN Position: Q2 2020 in Review
Affinity Investment Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,838 shares — an estimated $1.03M sold.
Affinity Investment Advisors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $21.6M in Q2 2013. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Affinity Investment Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Affinity Investment Advisors sold 5,838 Allergan plc shares in Q2 2020, an estimated $1.03M.
- Affinity Investment Advisors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Affinity Investment Advisors's Allergan plc position peaked at $21.6M in Q2 2013.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Affinity Investment Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.